Shen Y, Lu J, Hu F, Qian J, et al. Effect and outcomes analysis of anlotinib in non-small cell lung cancer patients with liver metastasis: results from the ALTER 0303 phase 3 randomized clinical trial. J Cancer Res Clin Oncol 2022 Apr 28. pii: 10.1007/s00432-022-03964.
PMID: 35482076